The comorbidity of diabetes mellitus and psychiatric disorders
Diabetes mellitus is a chronic disease affecting approximately 6% of the general population. Depression and schizophrenia are often comorbid with diabetes. There are two main ways to explain this phenomenon. Firstly, patients with diabetes mellitus have higher incidence of psychiatric disorders and...
| Permalink: | http://skupni.nsk.hr/Record/nsk.NSK01000744291/Details |
|---|---|
| Matična publikacija: |
Psychiatria Danubina 21 (2009), 4 ; str. 585-588 |
| Glavni autor: | Medved, Vesna (-) |
| Ostali autori: | Jovanović, Nikolina, liječnica (-), Popović-Knapić, Vesna |
| Vrsta građe: | Članak |
| Jezik: | eng |
| Predmet: | |
| Online pristup: |
http://hrcak.srce.hr/psychiatria-danubina |
| LEADER | 02193caa a2200289 i 4500 | ||
|---|---|---|---|
| 001 | NSK01000744291 | ||
| 003 | HR-ZaNSK | ||
| 005 | 20121107104838.0 | ||
| 007 | ta | ||
| 008 | 100927s2009 ci ||| ||eng | ||
| 035 | |a (HR-ZaNSK)000744291 | ||
| 040 | |a HR-ZaNSK |b hrv |c HR-ZaNSK |e ppiak | ||
| 042 | |a croatica | ||
| 044 | |a ci |c hr | ||
| 080 | |a 616 |2 MRF 1998. | ||
| 100 | 1 | |a Medved, Vesna | |
| 245 | 1 | 4 | |a The comorbidity of diabetes mellitus and psychiatric disorders / |c Vesna Medved, Nikolina Jovanović & V. [Vesna] Popović Knapić. |
| 500 | |a 4th Croatian congress on psychopharmacotherapy with international participation, Zadar, October 7-10, 2009 | ||
| 504 | |a Bibliografija: 16 jed | ||
| 520 | |a Diabetes mellitus is a chronic disease affecting approximately 6% of the general population. Depression and schizophrenia are often comorbid with diabetes. There are two main ways to explain this phenomenon. Firstly, patients with diabetes mellitus have higher incidence of psychiatric disorders and secondly, antidepressants and antipsychotics may cause metabolic abnormalities. Antidepressants with noradrenergic activity have the highest potential to cause metabolic abnormalities. In schizophrenia, the risk is highest with clozapine and olanzapine pose the highest risk, moderate for risperidone and quetiapine, while ziprasidone and sertindole have not been associated with diabetes. During the first three months, weight gain should be monitored on monthly basis, while biochemical analysis should be performed after the first three months, and then once a year. In patients with significant weight gain, increase of blood glucose level or dyslipidemia, the first intervention should be switch to another antipsychotic. If necessary, a patient should be referred to an endocrinologist and advised on changing their life style | ||
| 653 | 0 | |a Komorbiditet |a Dijabetes |a Depresija |a Shizofrenija |a Antidepresivi | |
| 700 | 1 | |a Jovanović, Nikolina, |c liječnica | |
| 700 | 1 | |a Popović-Knapić, Vesna | |
| 773 | 0 | |t Psychiatria Danubina |x 0353-5053 |g 21 (2009), 4 ; str. 585-588 | |
| 981 | |b B08/09 |p CRO | ||
| 998 | |a rado100927 |c vol2o121107 | ||
| 856 | 4 | 2 | |u http://hrcak.srce.hr/psychiatria-danubina |